Novartis dealt a blow in patent fight to block Entresto generics
Novartis on Friday faced a setback in a key patent case as it fights to keep generic versions of its heart drug Entresto off the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
